NascentPEP 1#
Natural health product licensed in Canada
- Other names
- NascentPEP Arginine Tablet, NascentPEP Energy Provider Tablet
- Licence holder
- Nascent Peptide Biotechnology Limited
- NPN or DIN-HM
- 80069348
- Status
- Inactive licence
- Licence date
- 11 May 2016
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-arginine Source : Monohydrochlorure de L-arginine | 850 milligramme | Not calculated |
Non-medicinal ingredients
Hydroxypropyl méthylcellulose, Albumen, Dioxyde de silicium, Talc, Stéarate de magnésium, Dioxyde de titane, Noyer commun, Poly(éthylène glycol)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 4 Comprimé ; maximum: 6 Comprimé | 2 Tous les jours |
Uses authorised in Canada
May help support a modest improvement in exercise capacity in individuals with stable cardiovascular diseases (CVD) . L-Arginine is a non-essential amino acid that is involved in protein synthesis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you have had a heart attack/myocardial infarction.
- Effets indésirables connus
Some people may experience gastrointestinal discomfort (such as diarrhea).
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner if your cardiovascular condition worsens. Consult a health care practitioner prior to use if you have a renal/kidney disease or if you are following a low protein diet. Consult a health care practitioner prior to use if you suffer from a cardiovascular disease and are attempting an increase in physical activity. Consult your health care practitioner prior to use if you are taking medication for cardiovascular diseases, erectile dysfunction, and/or blood thinners.
Source
Official Health Canada record, licence 80069348
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.